EW - Oppenheimer upgrades Edwards to outperform citing TTVR opportunity
2023-09-26 14:25:41 ET
More on Edwards Lifesciences
- Seeking Alpha’s Quant Rating on Edwards Lifesciences
- Edwards Lifesciences: Rising Dominance In Structural Heart Disease
- Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Call Transcript
- Edwards Lifesciences said to be the target of EU antitrust raid last week
- Medtech set for banner year after significant boost in H1 device approvals
For further details see:
Oppenheimer upgrades Edwards to outperform, citing TTVR opportunity